Publicaciones (55) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. A comprehensive diagnosis of a desmoplastic small round cell tumor of unusual location based on fine-needle aspiration cytology: Report of a case arising in the parotid gland and review of the literature

    Diagnostic Cytopathology, Vol. 48, Núm. 9, pp. 827-832

  2. Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion

    Journal of Cell Biology, Vol. 219, Núm. 9

  3. Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Molecular Therapy - Nucleic Acids, Vol. 21, pp. 192-204

  4. Atypia of undetermined significance

    The International System for Serous Fluid Cytopathology (Springer), pp. 41-52

  5. Avances en el manejo del cáncer de pulmón

    Anales del sistema sanitario de Navarra, Vol. 43, Núm. 2, pp. 131-139

  6. Brain ventricular enlargement in human and murine acute intermittent porphyria

    Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223

  7. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

    Immunity, Vol. 52, Núm. 5, pp. 856-871.e8

  8. Cb2 receptors and neuron–glia interactions modulate neurotoxicity generated by magl inhibition

    Biomolecules, Vol. 10, Núm. 8, pp. 1-15

  9. Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma

    Genome Research, Vol. 30, Núm. 9, pp. 1217-1227

  10. Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial

    Leukemia, Vol. 34, Núm. 7, pp. 1760-1774

  11. Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

  12. Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models

    Cancers, Vol. 12, Núm. 12, pp. 1-14

  13. Coupling of cerebral blood flow and functional connectivity is decreased in healthy aging

    Brain Imaging and Behavior, Vol. 14, Núm. 2, pp. 436-450

  14. Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence

    Modern Pathology, Vol. 33, Núm. 12, pp. 2507-2519

  15. Drugsniper, a tool to exploit loss-of-function screens, identifies CREBBP as a predictive biomarker of VOLASERTIB in small cell lung carcinoma (SCLC)

    Cancers, Vol. 12, Núm. 7, pp. 1-18

  16. Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors

    OncoImmunology, Vol. 9, Núm. 1

  17. Epigenetic SmAd3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma

    Cancer Research, Vol. 80, Núm. 2, pp. 276-290

  18. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates

    Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164

  19. Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum

    Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42

  20. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

    EBioMedicine, Vol. 53